BASTA JAMES (CIK 1792726) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy NTLA (46,080 shares), Sell NTLA (1,211 shares), Sell NTLA (10,397 shares), Buy NTLA (40,000 shares), Sell NTLA (2,572 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | Buy | 46,080 | $0 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | Sell | 1,211 | $16,688 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | Sell | 10,397 | $95,756 |
| 2025-03-04 | Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | Buy | 40,000 | $0 |
| 2025-03-04 | Intellia Therapeutics, Inc. (NTLA) | EVP, General Counsel | Sell | 2,572 | $23,122 |
Source: SEC Form 4 filings · as of 2026-03-03